237 related articles for article (PubMed ID: 9015312)
1. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells.
Airas L; Niemelä J; Salmi M; Puurunen T; Smith DJ; Jalkanen S
J Cell Biol; 1997 Jan; 136(2):421-31. PubMed ID: 9015312
[TBL] [Abstract][Full Text] [Related]
2. CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism.
Airas L; Niemelä J; Jalkanen S
J Immunol; 2000 Nov; 165(10):5411-7. PubMed ID: 11067892
[TBL] [Abstract][Full Text] [Related]
3. CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.
Airas L; Hellman J; Salmi M; Bono P; Puurunen T; Smith DJ; Jalkanen S
J Exp Med; 1995 Nov; 182(5):1603-8. PubMed ID: 7595232
[TBL] [Abstract][Full Text] [Related]
4. Decreased number of CD73 (ecto-5'-nucleotidase) molecules on lymphocytes from patients with primary immunoglobulin deficiencies. Correlation between number of CD73 molecules and T-lymphocyte function in vitro.
Christensen LD; Andersen V; Ryder L
Scand J Immunol; 1996 Jul; 44(1):62-70. PubMed ID: 8693293
[TBL] [Abstract][Full Text] [Related]
5. No correlation between CD73 expression and ecto-5'-nucleotidase activity on blood mononuclear cells in vitro. Evidence of CD73 (ecto-5'-nucleotidase) on blood mononuclear cells with distinct antigenic properties.
Christensen LD
APMIS; 1996 Feb; 104(2):126-34. PubMed ID: 8619914
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73).
Thomson LF; Ruedi JM; Glass A; Moldenhauer G; Moller P; Low MG; Klemens MR; Massaia M; Lucas AH
Tissue Antigens; 1990 Jan; 35(1):9-19. PubMed ID: 2137649
[TBL] [Abstract][Full Text] [Related]
7. Ecto-enzyme and signaling functions of lymphocyte CD73.
Resta R; Yamashita Y; Thompson LF
Immunol Rev; 1998 Feb; 161():95-109. PubMed ID: 9553767
[TBL] [Abstract][Full Text] [Related]
8. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation.
Niemelä J; Henttinen T; Yegutkin GG; Airas L; Kujari AM; Rajala P; Jalkanen S
J Immunol; 2004 Feb; 172(3):1646-53. PubMed ID: 14734746
[TBL] [Abstract][Full Text] [Related]
9. CD73 expression and fyn-dependent signaling on murine lymphocytes.
Yamashita Y; Hooker SW; Jiang H; Laurent AB; Resta R; Khare K; Coe A; Kincade PW; Thompson LF
Eur J Immunol; 1998 Oct; 28(10):2981-90. PubMed ID: 9808167
[TBL] [Abstract][Full Text] [Related]
10. CD73 mediates adhesion of B cells to follicular dendritic cells.
Airas L; Jalkanen S
Blood; 1996 Sep; 88(5):1755-64. PubMed ID: 8781432
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to 5'-nucleotidase (CD73), a glycosyl-phosphatidylinositol-anchored protein, cause human peripheral blood T cells to proliferate.
Thompson LF; Ruedi JM; Glass A; Low MG; Lucas AH
J Immunol; 1989 Sep; 143(6):1815-21. PubMed ID: 2550543
[TBL] [Abstract][Full Text] [Related]
12. Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73.
Resta R; Hooker SW; Laurent AB; Shuck JK; Misumi Y; Ikehara Y; Koretzky GA; Thompson LF
J Immunol; 1994 Aug; 153(3):1046-53. PubMed ID: 8027539
[TBL] [Abstract][Full Text] [Related]
13. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.
Terp MG; Olesen KA; Arnspang EC; Lund RR; Lagerholm BC; Ditzel HJ; Leth-Larsen R
J Immunol; 2013 Oct; 191(8):4165-73. PubMed ID: 24043904
[TBL] [Abstract][Full Text] [Related]
14. Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function.
Narravula S; Lennon PF; Mueller BU; Colgan SP
J Immunol; 2000 Nov; 165(9):5262-8. PubMed ID: 11046060
[TBL] [Abstract][Full Text] [Related]
15. CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes.
Takedachi M; Qu D; Ebisuno Y; Oohara H; Joachims ML; McGee ST; Maeda E; McEver RP; Tanaka T; Miyasaka M; Murakami S; Krahn T; Blackburn MR; Thompson LF
J Immunol; 2008 May; 180(9):6288-96. PubMed ID: 18424752
[TBL] [Abstract][Full Text] [Related]
16. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.
Niemelä J; Ifergan I; Yegutkin GG; Jalkanen S; Prat A; Airas L
Eur J Immunol; 2008 Oct; 38(10):2718-26. PubMed ID: 18825744
[TBL] [Abstract][Full Text] [Related]
17. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.
Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF
J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259
[TBL] [Abstract][Full Text] [Related]
18. 5'-Ectonucleotidase/CD73 expression on lymph-circulating lymphocytes and lymphatic endothelial cells offers new paths to explore barrier function.
Sidibé A; Imhof BA
Eur J Immunol; 2015 Feb; 45(2):371-5. PubMed ID: 25641680
[TBL] [Abstract][Full Text] [Related]
19. Ecto-5'-nucleotidase activity is not required for T cell activation through CD73.
Gutensohn W; Resta R; Misumi Y; Ikehara Y; Thompson LF
Cell Immunol; 1995 Apr; 161(2):213-7. PubMed ID: 7697732
[TBL] [Abstract][Full Text] [Related]
20. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
